Generative AI in Drug Discovery Market Trends, Share, and Growth Analysis 2035
According to Payal Rabde, who specializes in AI-driven drug design, target identification, molecular generation, virtual screening, lead optimization, drug repurposing, and pharmaceutical R&D, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the generative AI in drug discovery market. The global generative AI in drug discovery market size was estimated at USD 318.55 million in 2025 and is predicted to increase from USD 405.90 million in 2026 to approximately USD 3593.80 million by 2035, expanding at a CAGR of 27.42% from 2026 to 2035. The market is growing due to increasing demand for faster drug development, reduced R&D costs, improved molecular design, and accelerated identification of promising drug candidates.
Last Updated : 08 September 2026
Category: Therapeutic Area
Insight Code: 5816
Format: PDF / PPT / Excel